Avingtrans PLC (GB:AVG)
LSE:AVG
Top Page
Avingtrans
(LSE:AVG)
Select Model
Select Model
Rating:70Outperform
Price Target:
594.00 p
▲(23.75% Upside)
Action:UpgradedDate:12/07/25
Avingtrans' overall stock score is driven by strong financial performance and positive corporate events, which enhance its growth prospects. While the technical analysis suggests a neutral trend, the valuation indicates potential overvaluation. The absence of earnings call data limits insights into management's outlook.
Positive Factors
Low leverage / strong balance sheet
A low debt-to-equity ratio of 0.23 indicates conservative leverage, giving the company durable financial flexibility to fund capex or absorb project timing shocks. This strengthens credit resilience, supports bidding on long-term contracts, and reduces refinancing risk over months.
Negative Factors
Low absolute net profit margin
A net margin around 4.2% remains modest for an engineering group, limiting retained earnings and the buffer against cost inflation or project overruns. Even with improvement, low absolute margins constrain investment capacity and make results sensitive to single-project profit swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
A low debt-to-equity ratio of 0.23 indicates conservative leverage, giving the company durable financial flexibility to fund capex or absorb project timing shocks. This strengthens credit resilience, supports bidding on long-term contracts, and reduces refinancing risk over months.
Read all positive factors
Avingtrans (AVG) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£179.65M
Dividend Yield1.02%
Average Volume (3M)61.23K
Price to Earnings (P/E)10.7
Beta (1Y)0.52
Revenue Growth14.49%
EPS Growth76.33%
CountryUK
Employees941
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)0.15
Shares Outstanding33,269,320
10 Day Avg. Volume57,336
30 Day Avg. Volume61,226
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)1.20
Price to Sales (P/S)0.87
P/FCF Ratio15.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.3
Revenue Forecast (FY)£175.02M
Avingtrans Business Overview & Revenue Model
Company Description
Avingtrans plc manufactures and sells engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in three segments: Energy-EPM, Energy-PSRE, and Medical-MII. The company designs, manuf...
How the Company Makes Money
Avingtrans makes money primarily by selling engineered products and engineering services to industrial customers, with revenues typically generated through a combination of project-based contracts and repeat aftermarket/support work.
Key revenue ...
Avingtrans Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
| Breakdown | TTM | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.49M | 156.41M | 136.62M | 116.44M | 99.08M | 98.52M |
| Gross Profit | 48.50M | 47.36M | 44.04M | 36.86M | 32.59M | 28.38M |
| EBITDA | 16.70M | 15.75M | 12.54M | 13.20M | 12.02M | 11.03M |
| Net Income | 7.06M | 6.56M | 3.66M | 5.19M | 6.48M | 3.99M |
Balance Sheet | ||||||
| Total Assets | 196.40M | 192.76M | 186.34M | 155.41M | 154.69M | 142.61M |
| Cash, Cash Equivalents and Short-Term Investments | 5.62M | 8.56M | 12.12M | 17.72M | 24.29M | 30.08M |
| Total Debt | 27.28M | 25.47M | 23.96M | 8.58M | 10.96M | 9.80M |
| Total Liabilities | 76.54M | 77.53M | 73.33M | 46.96M | 48.88M | 43.65M |
| Stockholders Equity | 117.28M | 113.14M | 110.44M | 106.04M | 103.82M | 97.30M |
Cash Flow | ||||||
| Free Cash Flow | 11.11M | 8.80M | -11.06M | 985.00K | -1.10M | 4.03M |
| Operating Cash Flow | 14.29M | 11.61M | 1.33M | 9.68M | 3.88M | 6.45M |
| Investing Cash Flow | -14.67M | -14.29M | -13.58M | -12.52M | -9.35M | 24.56M |
| Financing Cash Flow | -4.05M | -436.00K | 6.78M | -3.40M | -371.00K | -5.85M |
Avingtrans Technical Analysis
Neutral
480.00
Price Trends
564.40
Negative
532.20
Positive
491.86
Positive
Market Momentum
-5.60
Negative
47.00
Neutral
47.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AVG, the sentiment is Neutral. The current price of 480 is below the 20-day moving average (MA) of 542.25, below the 50-day MA of 564.40, and below the 200-day MA of 491.86, indicating a neutral trend. The MACD of -5.60 indicates Negative momentum. The RSI at 47.00 is Neutral, neither overbought nor oversold. The STOCH value of 47.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:AVG.
Avingtrans Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £179.65M | 10.69 | 6.13% | 1.02% | 14.49% | 76.33% | |
65 Neutral | £102.61M | 7.63 | 3.83% | 6.69% | -13.30% | -60.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £1.08B | 22.48 | 8.58% | 3.30% | -6.95% | -52.08% | |
62 Neutral | £564.85M | 28.89 | 8.04% | 4.87% | -7.30% | -59.71% | |
61 Neutral | £71.42M | -2.99 | -13.68% | ― | 21.17% | -237.25% | |
44 Neutral | £392.03M | -8.61 | -14.17% | ― | 57.73% | -67.12% |
* Industrials Sector Average
GB:AVG
Avingtrans
540.00
228.36
73.28%
GB:BOY
Bodycote
632.00
166.57
35.79%
GB:CGS
Castings
236.00
-3.02
-1.26%
GB:ITM
ITM Power
63.50
35.70
128.42%
GB:MPAC
Mpac Group PLC
237.50
-147.50
-38.31%
GB:MGAM
Morgan Advanced Materials
204.50
33.65
19.69%
Avingtrans Corporate Events
Business Operations and StrategyProduct-Related Announcements
Avingtrans’ Scientific Magnetics Marks 20th Quantum Magnet Amid UK Push into Quantum Computing
Positive
Mar 26, 2026
Avingtrans’ Oxfordshire-based subsidiary Scientific Magnetics has shipped its 20th superconducting magnet for quantum computing, underscoring the group’s push into high-value, precision technologies that support emerging computing and ...
Business Operations and StrategyDividendsFinancial Disclosures
Avingtrans Lifts Profit and Dividend as Nuclear and Imaging Units Gain Momentum
Positive
Feb 25, 2026
Avingtrans reported flat first-half revenue of £78.1m but improved profitability, with gross margin rising to 31.7%, adjusted EBITDA up 10.4% to £9.6m and adjusted profit before tax up 27.1% to £5.7m. Cash generation strengthened, n...
Private Placements and FinancingRegulatory Filings and Compliance
Avingtrans Issues New Shares Following Employee Option Exercises
Neutral
Jan 27, 2026
Avingtrans has announced that certain non-board employees have exercised 138,900 options under the company’s CSOP scheme, resulting in the issue of an equivalent number of new ordinary shares and an application for their admission to trading...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Avingtrans Confirms In-Line First-Half Trading and Eyes Growth from AI, Data Centre and Nuclear Tailwinds
Positive
Jan 21, 2026
Avingtrans reported that trading for the first six months to 30 November 2025 was in line with management expectations, underpinned by continuing positive momentum across the Group, particularly in businesses exposed to AI and data centre demand a...
Business Operations and Strategy
Avingtrans Grants Share Options Tied to Inflation-Linked EPS Growth
Positive
Jan 12, 2026
Avingtrans plc has granted options over 293,000 ordinary shares to non-PDMR employees under its Share Option Plan, with an exercise price of 515.0 pence per share, as part of its long-term incentive arrangements. The options will vest after three ...
Business Operations and StrategyExecutive/Board Changes
Avingtrans Names Stuart Gall to Lead Medical and Industrial Imaging Division
Positive
Jan 12, 2026
Avingtrans has appointed experienced MedTech executive Stuart Gall as Chief Executive Officer of its medical and industrial imaging division, effective 1 January 2026, tasking him with driving the strategic development and commercialisation of por...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.